Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Share-based Compensation (2017 - 2025)

Historic Share-based Compensation for MedWellAI (MWAI) over the last 8 years, with Q3 2025 value amounting to $49250.0.

  • MedWellAI's Share-based Compensation changed N/A to $49250.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $648792.0, marking a year-over-year increase of 10781.68%. This contributed to the annual value of $599542.0 for FY2025, which is N/A changed from last year.
  • Per MedWellAI's latest filing, its Share-based Compensation stood at $49250.0 for Q3 2025.
  • MedWellAI's 5-year Share-based Compensation high stood at $14.8 million for Q2 2023, and its period low was -$8.3 million during Q4 2023.
  • For the 5-year period, MedWellAI's Share-based Compensation averaged around $1.5 million, with its median value being $207500.0 (2022).
  • Examining YoY changes over the last 5 years, MedWellAI's Share-based Compensation showed a top increase of 390000.0% in 2023 and a maximum decrease of 410000.0% in 2023.
  • MedWellAI's Share-based Compensation (Quarter) stood at $1.9 million in 2021, then plummeted by 88.96% to $207500.0 in 2022, then tumbled by 4100.0% to -$8.3 million in 2023, then surged by 100.58% to $48125.0 in 2024, then rose by 2.34% to $49250.0 in 2025.
  • Its last three reported values are $49250.0 in Q3 2025, $49250.0 for Q2 2025, and $502167.0 during Q1 2025.